OTIVIDEX Trademark

Trademark Overview

On Friday, April 28, 2017, a trademark application was filed for OTIVIDEX with the United States Patent and Trademark Office. The USPTO has given the OTIVIDEX trademark a serial number of 87982412. The federal status of this trademark filing is REGISTERED as of Tuesday, February 4, 2020. This trademark is owned by Otonomy, Inc.. The OTIVIDEX trademark is filed in the Pharmaceutical Products category with the following description:

Sustained release therapeutic formulations for the ear; pharmaceuticals for the treatment or prevention of disorders and diseases of the ear
otividex

General Information

Serial Number87982412
Word MarkOTIVIDEX
Filing DateFriday, April 28, 2017
Status700 - REGISTERED
Status DateTuesday, February 4, 2020
Registration Number5978958
Registration DateTuesday, February 4, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 24, 2017

Trademark Statements

Goods and ServicesSustained release therapeutic formulations for the ear; pharmaceuticals for the treatment or prevention of disorders and diseases of the ear

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 4, 2017
Primary Code005
First Use Anywhere DateThursday, October 3, 2019
First Use In Commerce DateThursday, October 3, 2019

Trademark Owner History

Party NameOtonomy, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameOtonomy, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameOtonomy, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Tuesday, February 4, 2020REGISTERED-PRINCIPAL REGISTER
Saturday, December 28, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, December 27, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, December 6, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 5, 2019STATEMENT OF USE PROCESSING COMPLETE
Monday, November 18, 2019USE AMENDMENT FILED
Thursday, December 5, 2019DIVISIONAL PROCESSING COMPLETE
Monday, November 18, 2019DIVISIONAL REQUEST RECEIVED
Thursday, December 5, 2019EXTENSION 4 GRANTED
Monday, November 18, 2019EXTENSION 4 FILED
Thursday, December 5, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 18, 2019TEAS REQUEST TO DIVIDE RECEIVED
Monday, November 18, 2019TEAS EXTENSION RECEIVED
Monday, November 18, 2019TEAS STATEMENT OF USE RECEIVED
Saturday, June 8, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 6, 2019EXTENSION 3 GRANTED
Thursday, June 6, 2019EXTENSION 3 FILED
Thursday, June 6, 2019TEAS EXTENSION RECEIVED
Saturday, December 8, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 6, 2018EXTENSION 2 GRANTED
Thursday, December 6, 2018EXTENSION 2 FILED
Thursday, December 6, 2018TEAS EXTENSION RECEIVED
Friday, June 1, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 30, 2018EXTENSION 1 GRANTED
Wednesday, May 30, 2018EXTENSION 1 FILED
Wednesday, May 30, 2018TEAS EXTENSION RECEIVED
Tuesday, December 19, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 24, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 24, 2017PUBLISHED FOR OPPOSITION
Wednesday, October 4, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 12, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 12, 2017EXAMINER'S AMENDMENT ENTERED
Tuesday, September 12, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 12, 2017EXAMINERS AMENDMENT E-MAILED
Tuesday, September 12, 2017EXAMINERS AMENDMENT -WRITTEN
Tuesday, August 1, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 1, 2017NON-FINAL ACTION E-MAILED
Tuesday, August 1, 2017NON-FINAL ACTION WRITTEN
Wednesday, July 26, 2017ASSIGNED TO EXAMINER
Thursday, May 4, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, May 2, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

otividex prevention disorders diseases treatment pharmaceuticals release therapeutic formulations sustained